Registry-listed formulations

albaconazole · mesh:C112424

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

9 source entries across 4 studies. This list may not include all unresolved or historical entries.

  • Albaconazole oral solutionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Albaconazole 100mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Albaconazole 200mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Albaconazole 400mgRegistry intervention

    Molecular identity unconfirmed

    View study and source
  • Albaconazole 400mgRegistry intervention

    Molecular identity unconfirmed

    View study and source
  • Albaconazole tablet 400mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • AlbaconazoleRegistry product

    Named ingredient; product remains distinct

    Formulation reported by source: CAPSULE, HARD

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • AlbaconazoleRegistry product

    Named ingredient; product remains distinct

    Formulation reported by source: CAPSULE, HARD

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source
  • AlbaconazoleRegistry product

    Named ingredient; product remains distinct

    Formulation reported by source: CAPSULE, HARD

    Named ingredient; exact form unconfirmed. This mention does not add to the molecule trial count.

    View study and source

Success Metrics

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)

Phase Distribution

Phase 1
1
25%
Phase 2
3
75%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 23 (75.0%)

Trials by Status

completed250%
unknown125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

NCT00730405
completedphase_1

A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule

NCT01039883
terminatedphase_2

Efficacy Vulvovaginitis Candida

NCT00199264
unknownphase_2

A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus fluconazole and placebo in the treatment of acute Candida vulvovaginitis

SYFe2d356b1d3114ce59923bb7fb7e0ce9e

Clinical Trials (4)

Showing 4 of 4 trials
NCT00730405Phase 2

Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

Completed
NCT01039883Phase 1

A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule

Completed
NCT00199264Phase 2

Efficacy Vulvovaginitis Candida

Terminated
SYFe2d356b1d3114ce59923bb7fb7e0ce9ePhase 2

A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus fluconazole and placebo in the treatment of acute Candida vulvovaginitis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
4

External References

ChEMBL
CHEMBL298817

Names & Codes

Research Codes

UR 9825W-0027